Location: Redwood City, CA
CIK: 0001582844 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $142M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 84,901 | $27.35M | 19.3% | $100.08 | +211.6% | COM NEW | 74006W207 |
| TERN | TERNS PHARMACEUTICALS INC | 495,772 | $26.14M | 18.4% | $9.17 | +308.4% | COM | 880881107 |
| WHWK | WHITEHAWK THERAPEUTICS INC | 3,410,402 | $11.77M | 8.3% | $16.10 | -82.5% | COM | 00032Q104 |
| TNGX | TANGO THERAPEUTICS INC | 441,831 | $9.243M | 6.5% | $9.80 | +21.5% | COM | 87583X109 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 111,996 | $8.172M | 5.8% | $48.36 | +73.7% | COM NEW | 10919W405 |
| STRO | SUTRO BIOPHARMA INC | 269,425 | $6.711M | 4.7% | $13.68 | +10.2% | COM | 869367201 |
| ERAS | ERASCA INC | 354,575 | $5.737M | 4.0% | $10.02 | 0.0% | COM | 29479A108 |
| SRZN | SURROZEN INC | 172,847 | $5.035M | 3.6% | $11.57 | +92.1% | COM NEW | 86889P208 |
| OCUL | OCULAR THERAPEUTIX INC | 592,108 | $5.015M | 3.5% | $6.18 | +59.0% | COM | 67576A100 |
| CMPX | COMPASS THERAPEUTICS INC | 849,076 | $4.492M | 3.2% | $3.50 | +71.6% | COM | 20454B104 |
| NERV | MINERVA NEUROSCIENCES | 709,500 | $4.275M | 3.0% | $3.71 | +33.7% | COM NEW | 603380205 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 191,760 | $3.574M | 2.5% | $14.74 | +8.9% | CLASS ORD A | 61559X104 |
| ARGX | ARGEN SE - ADR | 4,690 | $3.425M | 2.4% | $489.55 | — | SPONSORED ADR | 04016X101 |
| OCS | OCULIS HOLDING AG | 98,339 | $2.615M | 1.8% | $20.50 | +29.2% | ORDINARY SHARES | H5870P102 |
| RVMD | REVOLUTION MEDICINES INC | 26,069 | $2.535M | 1.8% | $77.81 | +32.4% | COM | 76155X100 |
| — | 4D MOLECULAR THERAPEUTICS INC | 242,255 | $2.255M | 1.6% | $9.31 | — | COM | 35104E104 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 151,067 | $2.1M | 1.5% | $9.41 | +48.6% | COM | 03237H101 |
| TSHA | TAYSHA GENE THERAPIES INC | 439,464 | $1.964M | 1.4% | $2.17 | +119.1% | COM SHS | 877619106 |
| IDYA | IDEAYA BIOSCIENCES INC | 48,234 | $1.607M | 1.1% | $33.87 | 0.0% | COM | 45166A102 |
| DSGN | DESIGN THERAPEUTICS INC | 145,900 | $1.552M | 1.1% | $7.83 | +27.5% | COM | 25056L103 |
| UTHR | UNITED THERAPEUTICS CORP | 2,224 | $1.319M | 0.9% | $336.31 | +42.9% | COM | 91307C102 |
| IDYA | IDEAYA BIOSCIENCES INC | 350 | $1.166M | 0.8% | $33.87 | 0.0% | Call | 45166A102 |
| TRDA | ENTRADA THERAPEUTICS INC | 89,358 | $1.128M | 0.8% | $12.62 | — | COM | 29384C108 |
| AVTX | AVALO THERAPEUTICS INC | 60,808 | $908K | 0.6% | $15.50 | 0.0% | COM NEW | 05338F306 |
| LBRX | LB PHARMACEUTICALS INC | 28,919 | $713K | 0.5% | $15.87 | +41.1% | COM SHS | 50180M108 |
| MAZE | MAZE THERAPEUTICS INC | 19,335 | $577K | 0.4% | $34.37 | +28.1% | COM | 578784100 |
| UNCY | UNICYCIVE THERAPEUTICS INC | 57,959 | $381K | 0.3% | $6.18 | +3.7% | COM | 90466Y202 |